FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Genentech Breakthrough Status on Alzheimers Drug

[ Price : $8.95]

FDA grants Genentech a breakthrough therapy designation for gantenerumab, an anti-amyloid beta antibody developed for subcutaneous...

Warning on Needle-free Devices for Dermal Fillers

[ Price : $8.95]

FDA issues a warning to health care professionals to not use needle-free devices such as hyaluron pens for injecting hyaluronic a...

FDA Reclassifies Surgical Staplers, Staples

[ Price : $8.95]

FDA reclassifies surgical staplers for internal use from Class 1 to Class 2 and delays enforcement of the change for 180 days.

De Novo Sought for Fibromyalgia Neuromodulator

[ Price : $8.95]

NeuroMetrix submits a de novo request for its Quell wearable neuromodulation device for treating symptoms of fibromyalgia in adul...

Panel to Discuss Moderna, Janssen Vaccine Boosters

[ Price : $8.95]

Federal Register notice: FDA announces a 10/14-15 Vaccines and Related Biological Products Advisory Committee meeting.

Revised Guide on Hospital Drug Compounding

[ Price : $8.95]

Federal Register notice: FDA releases a revised draft guidance entitled Hospital and Health System Compounding Under Section 503A ...

Imperative Care Zoom Catheter Recall is Class 1

[ Price : $8.95]

FDA says the Imperative Care recall of specific lots of its ZOOM 71 reperfusion catheter is Class 1.

Info Collection Revision on Device Labeling

[ Price : $8.95]

Federal Register notice: FDA sends to OMB an information collection revision entitled Medical Device Labeling Regulations.

FDA Recognizes Molecular Tumor Marker Database

[ Price : $8.95]

FDA recognizes a partial listing of the Memorial Sloan Kettering Cancer Center Oncology Knowledge Base.

Biden Nearing His FDA Commissioner Pick

[ Price : $8.95]

The Biden Administration signals that it is nearing its choice of a nominee for FDA commissioner.